For research and laboratory use only. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
Tesamorelin
Tesamorelin from Primeva Labs is offered strictly for research use only. Each order includes batch-specific CoA documentation, quality verification, and secure online ordering. Not for human or animal consumption.
Primeva Labs supplies materials strictly for laboratory and research use. Create a complimentary research account to view current pricing, availability, and ordering.
By creating an account you confirm you are 21+, agree to the Terms & Research-Use Disclaimer, and acknowledge these products are sold strictly for research use — not for human or animal consumption.
What Is Tesamorelin?
Tesamorelin is a stabilized GHRH analog studied in metabolic and adipose-tissue research, notably visceral-fat and lipid-pathway models.
- Stabilized analog of growth-hormone-releasing hormone
- Studied in visceral-fat and lipid-metabolism research
- One of the most clinically characterized GHRH analogs
- Supplied strictly as a research-grade reference material
Research Applications
Visceral-fat research
Studied for effects on visceral adipose tissue in metabolic models.
Lipid-pathway research
Examined for influence on triglyceride and lipid handling via the GH/IGF-1 axis.
GH-axis research
Studied as a GHRH-receptor agonist that stimulates GH release.
Liver-fat models
Investigated in research on hepatic fat accumulation.
Proposed Mechanisms
GHRH-receptor agonism
Binds the pituitary GHRH receptor to stimulate growth-hormone release.
Enhanced stability
An N-terminal modification improves stability versus native GHRH, prolonging activity.
GH/IGF-1 lipolysis
Elevated GH is studied for downstream lipolytic effects on visceral fat.
Hepatic lipid handling
Examined for influence on liver-fat metabolism in preclinical and clinical work.
Mechanisms described above are drawn from preclinical (cell and animal) research and, where noted, early clinical literature. They are provided for educational context and should not be read as clinical or therapeutic claims.
